when to use 5-alpha-reductase inhibitors (Proscar, Avodart) or PSA screening to prevent prostate cancer

July 2009

See updated FDA information concerning the use of 5-alpha reductase inhibitors and increased risk of serious forms of prostate cancer

Experts are debating when to use 5-alpha-reductase inhibitors (Proscar, Avodart) or PSA screening to prevent prostate cancer.

Proscar and Avodart. These 5-alpha-reductase inhibitors can prevent prostate cancer due to their anti-androgen effects.

Statistically, you need to treat 71 men for up to 7 years to prevent one case of prostate cancer.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

  • 12 issues every year — what you need to know and do, right now
  • Quick, practical reference charts and tools
  • Comprehensive CE library to meet license renewal and state requirements
  • Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
  • Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote